Drawing on the expertise of multi-disciplinary research teams, the map developed by the 1000 Genomes Project will provide a view of biomedically relevant DNA variations at a resolution unmatched by current resources. The European Bioinformatics Institute (EBI), working with long-term collaborator the US National Institute of Biotechnology Information (NCBI), will make the data swiftly available to the worldwide scientific community through freely available public databases.
The EBI and NCBI will collect and analyse sequence generated by the Wellcome Trust Sanger Institute, the Beijing Genomics Institute, Shenzhen, China, and the USA’s National Human Genome Research Institute Large-Scale Sequencing Network.
During its two-year production phase, the 1000 Genomes Project will deliver sequence at an average rate of about 8.2 billion bases per day, the equivalent of more than two human genomes every 24 hours. The volume of data – and the interpretation of those data – will pose a major challenge for leading experts in the fields of bioinformatics and statistical genetics.
It’s a challenge that Paul Flicek, lead investigator on the EBI’s part of the project, is eager to rise to. ‘The 1000 Genomes Project represents an important step in relating DNA sequence information to each individual’s risk of disease and response to drugs – we’re on the cusp of building an important bridge between biology and medicine,’ he says.Contact:
Anna-Lynn Wegener, EMBL Press Officer, Heidelberg, Germany, Tel: +49 6221 387 452, www.embl.org, email@example.com
Anna-Lynn Wegener | EMBL
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy